A comprehensive guide to ICD-10 code for transaminitis

In the intricate symphony of human physiology, the liver performs a silent, relentless concerto of metabolic functions. Often, its first cry for help is not pain or jaundice, but a subtle, biochemical whisper found on a routine blood test: elevated transaminases. This finding, clinically termed “transaminitis,” is one of the most common and clinically significant challenges encountered in modern medicine. It is a gateway to a vast differential diagnosis, spanning from benign, self-limiting conditions to life-threatening chronic diseases. For the healthcare provider, it prompts a detective-like investigation into the patient’s history, habits, and overall health. For the medical coder, it presents a unique and complex puzzle: how to accurately translate this nonspecific laboratory abnormality into the precise, alphanumeric language of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM).

The assignment of an ICD-10 code for transaminitis is far from a mundane administrative task. It is a critical step that bridges clinical medicine with healthcare administration, epidemiology, and finance. An accurately chosen code ensures appropriate reimbursement, contributes to valuable public health data, and facilitates quality care tracking. Conversely, an imprecise or incorrect code can lead to claim denials, skewed health statistics, and a fragmented understanding of the patient’s condition. This article aims to be the definitive guide for clinicians, medical coders, students, and healthcare administrators seeking to master the art and science of ICD-10 coding for transaminitis. We will embark on a detailed journey from the basic pathophysiology of liver enzyme elevation, through the labyrinth of the ICD-10-CM manual, to the practical application of coding principles in complex clinical scenarios. Our goal is to move beyond the generic code and embrace the specificity that modern medicine demands and deserves.

2. Understanding Transaminitis: More Than Just a Number

2.1. The Liver: The Body’s Metabolic Powerhouse

To understand transaminitis, one must first appreciate the liver’s monumental role. Located in the right upper quadrant of the abdomen, this largest internal organ is a metabolic factory, responsible for over 500 vital functions. These include:

• Detoxification: Metabolizing drugs, alcohol, and metabolic waste products.

• Protein Synthesis: Producing albumin, clotting factors, and other essential proteins.

• Bile Production: Essential for the digestion and absorption of fats.

• Glucose Homeostasis: Storing glycogen and regulating blood sugar levels.

• Vitamin and Mineral Storage: Storing vitamins A, D, B12, and iron.

The liver’s functional unit is the lobule, composed of hepatocytes (liver cells). The health of these hepatocytes is directly reflected in the levels of enzymes they contain, which leak into the bloodstream upon cellular injury or death.

2.2. Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST): The Cellular Sentinels

Transaminitis specifically refers to the elevation of two key enzymes: Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST).

• Alanine Aminotransferase (ALT): This enzyme is primarily found in the cytoplasm of hepatocytes. While it exists in other tissues, its concentration is highest in the liver. Therefore, an elevated ALT level is considered a more specific marker for hepatocellular injury than AST. When liver cells are damaged, their membranes become permeable, and ALT is released into the circulation.

• Aspartate Aminotransferase (AST): AST is found in the cytoplasm and mitochondria of cells. It is present not only in the liver but also in significant quantities in cardiac muscle, skeletal muscle, kidneys, brain, and red blood cells. Consequently, an isolated AST elevation can be due to non-hepatic causes, such as a myocardial infarction or rhabdomyolysis.

The pattern and ratio of ALT to AST elevation can provide valuable diagnostic clues. For instance, in classic alcoholic liver disease, the AST is often twice the level of the ALT (an AST:ALT ratio of 2:1 or greater). In viral hepatitis, both enzymes are typically elevated, with ALT often higher than AST.

2.3. What Does “Transaminitis” Really Mean? A Symptom, Not a Disease

It is paramount to recognize that “transaminitis” is a descriptive term for a laboratory finding, not a final diagnosis. It is analogous to “fever” or “anemia”—it indicates a problem exists but does not define its origin. The clinical significance of transaminitis ranges from trivial to critical. Mild, transient elevations can occur after strenuous exercise or with certain medications, while severe, persistent elevations may signal acute liver failure, cirrhosis, or metastatic cancer.

The clinician’s role is to investigate the etiology, and the coder’s role is to assign the code that most accurately reflects the established diagnosis. Relying solely on the term “transaminitis” without seeking its underlying cause is a disservice to both the patient and the integrity of the medical record.

3. The ICD-10-CM Coding System: A Language of Precision

3.1. The Philosophy Behind ICD-10

The International Classification of Diseases is a global health information standard for morbidity and mortality statistics, maintained by the World Health Organization (WHO). The Clinical Modification (CM) used in the United States is a more detailed version designed for classifying patient encounters and diseases. The transition from ICD-9 to ICD-10 in 2015 represented a monumental leap in specificity. ICD-10-CM contains over 70,000 codes compared to approximately 14,000 in ICD-9, allowing for a much more granular description of a patient’s condition, including laterality, etiology, severity, and encounter type.

3.2. Structure of an ICD-10-CM Code

An ICD-10-CM code can be anywhere from three to seven characters long. Each character adds a layer of specificity.

• Category: The first three characters. (e.g., K70 for Alcoholic liver disease).

• Etiology, Anatomy, Severity: Characters four through six provide more detail. (e.g., K70.10 for Alcoholic hepatitis without ascites).

• Extension: The seventh character is often used for encounter specifics, such as initial, subsequent, or sequela. This is common in injury and external cause codes.

This hierarchical structure forces the coder and clinician to think deeply about the exact nature of the patient’s illness.

4. Navigating the ICD-10-CM Index for Transaminitis

A coder beginning their search will start with the Alphabetic Index. Looking up “Transaminitis” will yield a direct cross-reference:

Transaminitis – see Elevation, transaminase

Following this reference to “Elevation” leads to:

Elevation
transaminase R74.0

This seems straightforward. However, a proficient coder knows that the Index is merely a starting point. The next, and most critical, step is to turn to the Tabular List to review the full code description, any instructional notes, and exclusion categories.

5. A Deep Dive into Code R74.0: Elevation of Levels of Transaminase and Lactic Acid Dehydrogenase (LDH)

5.1. Code Definition and Scope

In the Tabular List, under Chapter 18: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99), we find:

R74 Abnormal serum enzyme levels
R74.0 Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

This code is explicitly for when the elevation of these enzymes is a documented finding, but a definitive diagnosis for the cause has not been established. It is a symptom code, a placeholder for an abnormal lab result awaiting a clinical explanation.

5.2. Parent Code Notes and the R70-R79 Chapter

The parent code R74 includes a note: Abnormal levels of serum enzymes, other than transaminase and LDH, are coded elsewhere. This directs the coder to other codes for elevations of enzymes like amylase (R74.8) or alkaline phosphatase (which often has its own codes under liver or bone disorders).

It is also crucial to understand the purpose of Chapter 18. The chapter includes a vital instruction: This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions for which no diagnosis classifiable elsewhere is recorded. The key phrase is “for which no diagnosis classifiable elsewhere is recorded.” This means that if a definitive diagnosis is known, it must be coded instead of the R code.

5.3. Key Exclusions from R74.0

The “Excludes1” note for R74.0 is critical. An Excludes1 note means “NOT CODED HERE!” and indicates that the two conditions cannot be coded together because they are mutually exclusive.

R74.0 Excludes1: abnormal findings related to a disorder of the liver (K70-K77)

This is the most important rule governing the use of R74.0. If the patient has a diagnosed liver disorder—such as alcoholic hepatitis, viral hepatitis, or non-alcoholic steatohepatitis—you must not use R74.0. You must use the specific code from the K70-K77 range. The transaminitis is a symptom of that liver disorder, and coding the disorder inherently includes the symptom.

6. The Critical Importance of Specificity: Moving Beyond R74.0

6.1. The Pitfall of Defaulting to R74.0

Using R74.0 as a default for any elevated liver enzyme is a common but significant coding error. It is a symptom code that provides no information about the cause, severity, or chronicity of the condition. From a clinical care perspective, it fails to communicate the patient’s true health status. From a data analytics perspective, it groups all causes of liver injury into one uninformative bucket, preventing accurate tracking of disease prevalence. From a financial perspective, it may lead to under-reimbursement or denial of claims, as payers often expect a definitive diagnosis for medical necessity.

6.2. The Coder’s Quest for a Definitive Diagnosis

The primary directive for a medical coder is to code to the highest level of specificity known. This often requires a careful review of the entire medical record—the history and physical, consultation notes, progress notes, and diagnostic test results. The coder is not making a diagnosis, but they are responsible for translating the physician’s established diagnosis into the correct code. If the documentation states “elevated LFTs due to statin therapy,” the coder must find the code for drug-induced liver injury, not R74.0. If the note says “transaminitis in the setting of uncontrolled diabetes, likely due to NAFLD,” the coder must query the provider for a more specific diagnosis or, if confirmed, code the NAFLD.

7. Coding by Etiology: A Practical Guide for Common Causes of Transaminitis

This section is the core of accurate coding. The following table and subsequent explanations detail how to code transaminitis based on its underlying cause.

 ICD-10-CM Coding for Common Causes of Transaminitis

7.1. Drug-Induced Liver Injury (DILI)

Code Range: K71.- Toxic liver disease
This category is used when a drug or toxin is identified as the cause of the liver injury. It requires high specificity.

• Coding Steps:

  1. Identify the specific type of liver injury from the documentation (e.g., cholestatic, hepatocellular, acute).

  2. Assign the appropriate K71 code (e.g., K71.0 – Toxic liver disease with cholestasis, K71.1 – Toxic liver disease with hepatic necrosis).

  3. Crucially, use an additional code from Chapter 19 (Injury, poisoning, and certain other consequences of external causes, T36-T50) to identify the causative drug. For example, T46.6X5A for Adverse effect of statins, initial encounter.

• Example: A patient presents with jaundice and markedly elevated ALT/AST after starting a new antibiotic. The physician diagnoses “Acute drug-induced hepatocellular liver injury due to Augmentin.” The correct codes would be K71.1 (Toxic liver disease with hepatic necrosis) and T36.0X5A (Adverse effect of penicillins, initial encounter).

7.2. Alcoholic Liver Disease (ALD)

Code Range: K70.- Alcoholic liver disease
These codes are highly specific and require the physician to explicitly link the liver disease to alcohol use.

• Common Codes:

  • K70.10 Alcoholic hepatitis without ascites

  • K70.11 Alcoholic hepatitis with ascites

  • K70.30 Alcoholic cirrhosis of liver without ascites

  • K70.31 Alcoholic cirrhosis of liver with ascites

• Important Note: Do not assume alcoholism based on social history. The documentation must state a diagnosis like “alcoholic hepatitis” or “alcohol-induced cirrhosis.” If the provider only documents “elevated LFTs” and a history of heavy ETOH use, a query may be necessary.

7.3. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)

These are among the most common causes of chronic liver disease and transaminitis today, strongly associated with metabolic syndrome.

• K76.0 – Fatty (change of) liver, not elsewhere classified: This code is for simple steatosis (fat accumulation) without significant inflammation. It is often used for NAFLD.

• K75.81 – Non-alcoholic steatohepatitis (NASH): This is a specific code for the more advanced form, which includes inflammation and liver cell damage, potentially leading to fibrosis and cirrhosis. If the provider documents NASH, this code must be used instead of K76.0.

7.4. Viral Hepatitis (Acute and Chronic)

Code Range: B15-B19 Viral hepatitis
This block provides extreme specificity based on the virus (A, B, C, etc.) and the acuity of the infection (acute vs. chronic).

• Examples:

  • Acute Hepatitis A: B15.9

  • Acute Hepatitis B: B16.9

  • Chronic Hepatitis C: B18.2

  • Unspecified Viral Hepatitis: B19.9 (a less specific code to be used only if the type is unknown).

7.5. Autoimmune Hepatitis

This is coded to K75.4 – Autoimmune hepatitis. It is a single, specific code for this chronic inflammatory condition.

7.6. Ischemic Hepatitis (Shock Liver)

This occurs from poor perfusion to the liver, often in the context of heart failure, hypovolemic shock, or sepsis. There is no specific ICD-10 code for “ischemic hepatitis.” The most appropriate code is typically K76.89 – Other specified diseases of liver. The clinical documentation must clearly state the diagnosis to support the use of this code.

8. The Synergy Between Clinician and Coder: The Power of Documentation

The accuracy of medical coding is entirely dependent on the quality of clinical documentation. A coder can only code what is documented.

8.1. What Coders Need from the Medical Record

Coders look for clear, unambiguous statements that define the patient’s condition. They need:

• A definitive diagnosis: “Patient has non-alcoholic steatohepatitis,” not just “transaminitis.”

• Etiology: “Elevated AST/ALT secondary to his daily alcohol consumption.”

• Specificity: “Alcoholic hepatitis,” not just “alcoholic liver disease.”

• Laterality and Acuity: Where applicable.

8.2. Best Practices for Clinicians Documenting Transaminitis

To ensure accurate coding and optimal patient care, clinicians should:

1. Avoid using “transaminitis” as a final diagnosis. Use it as a finding that leads to a diagnosis.

2. Be specific in the assessment/plan. Instead of “Elevated LFTs,” write “Elevated LFTs, etiology consistent with drug-induced liver injury from [Drug Name].”

3. Link conditions to their cause. “Cirrhosis due to chronic Hepatitis C,” “Acute hepatitis due to CMV.”

4. Respond promptly to coder queries. If a coder asks for clarification on a diagnosis, a timely response ensures the record is coded correctly.

9. Clinical and Administrative Implications of Accurate Coding

9.1. Impact on Patient Care and Population Health

Precise ICD-10 coding creates a rich, searchable data ecosystem. It allows health systems to:

• Identify patient cohorts: Easily find all patients with NASH for a clinical trial or a disease management program.

• Track outcomes: Monitor the effectiveness of treatments for specific liver diseases.

• Conduct epidemiological research: Accurately track the incidence and prevalence of different causes of liver disease at a local, regional, and national level.

9.2. Impact on Reimbursement and Compliance

ICD-10 codes are the foundation of the medical billing process. They justify the medical necessity of the services provided.

• DRGs and APCs: In inpatient (DRG) and outpatient (APC) settings, the assigned diagnosis codes directly determine the reimbursement level. A nonspecific code like R74.0 will typically map to a lower-paying DRG/APC than a specific code like K75.81 (NASH).

• Claim Denials: If a payer’s policy requires a specific diagnosis for a certain test or procedure (e.g., a fibroscan for staging fibrosis in a hepatitis C patient), and the claim is submitted with only R74.0, it will likely be denied.

• Compliance Risks: Consistently using unspecified codes when more specific information is available in the record can be flagged as a compliance issue during audits, potentially leading to recoupments and penalties.

10. Case Studies: Applying Knowledge to Real-World Scenarios

Case Study 1: The Routine Physical
*A 55-year-old man with type 2 diabetes and hyperlipidemia has a routine physical. Blood work reveals ALT 85 U/L, AST 78 U/L. The physician’s note states: “Asymptomatic transaminitis. Likely related to his fatty liver disease.”*

• Initial Coding Thought: R74.0

• Correct Coding Action: This is insufficient. The physician has implied a diagnosis of NAFLD. A coder should query the physician to confirm. If the physician confirms “Non-alcoholic fatty liver disease,” the correct code is K76.0.

Case Study 2: The Hospitalized Patient
*A 40-year-old woman is admitted with upper abdominal pain, nausea, and jaundice. Her ALT is 1200, AST 1100. She has a history of heavy alcohol use. The discharge summary diagnosis is “Alcoholic Hepatitis.”*

• Initial Coding Thought: R74.0

• Correct Coding Action: The definitive diagnosis is “Alcoholic Hepatitis.” Per the Excludes1 note under R74.0, you cannot use it. The correct code is K70.10 (Alcoholic hepatitis without ascites) or K70.11 (with ascites), based on the clinical documentation.

Case Study 3: The Medication Side Effect
A patient on long-term amiodarone for arrhythmia is found to have gradually rising liver enzymes. A liver biopsy is performed, showing phospholipidosis. The final diagnosis is “Amiodarone-induced phospholipidosis and liver toxicity.”

• Initial Coding Thought: R74.0

• Correct Coding Action: This is a clear case of DILI. The correct codes are K71.8 (Toxic liver disease with other disorders of liver) and T46.2X5A (Adverse effect of other antidysrhythmic drugs, initial encounter).

11. Conclusion

Transaminitis is a common clinical signpost pointing to a wide array of potential liver insults. The ICD-10 code R74.0 serves as a temporary label for this finding when a cause is unknown. However, the paramount goal in medical coding is to transcend this nonspecific code and assign a definitive diagnosis from the K70-K77 range or elsewhere. Achieving this requires a collaborative effort between clinicians, who must provide detailed and specific documentation, and coders, who must be diligent investigators within the medical record. Mastering this process is not merely an administrative exercise; it is fundamental to ensuring high-quality patient care, robust clinical research, and a financially sound healthcare system.

12. Frequently Asked Questions (FAQs)

Q1: Can I code both R74.0 and a specific liver disease code (like K76.0 for NAFLD) together?
A: No. According to the ICD-10-CM Official Guidelines and the Excludes1 note under R74.0, you cannot code R74.0 with a code for a disorder of the liver (K70-K77). The specific liver disease code encompasses the finding of transaminitis.

Q2: What if the doctor only documents “elevated LFTs” and doesn’t specify a cause?
A: If a cause is not documented after a reasonable workup, then R74.0 is the correct code. However, if the clinical context strongly suggests a cause (e.g., the patient is known to have Hepatitis C), it is best practice for the coder to query the provider for a more definitive diagnosis.

Q3: How do I code elevated liver enzymes in a patient with heart failure?
A: This depends on the physician’s documentation. If the enzyme elevation is attributed to passive hepatic congestion from right-sided heart failure, you would code K76.1 (Chronic passive congestion of liver). If it is deemed to be “ischemic hepatitis” from a low-output state, you would use K76.89 (Other specified diseases of liver). You would also code the underlying heart failure (I50.-). Do not use R74.0.

Q4: Is there a different code for mild vs. severe transaminitis?
A: No, the ICD-10-CM code R74.0 does not specify severity. The severity is captured in the clinical documentation and the actual lab values. For some specific liver diseases, there are codes for “with” or “without” complications (e.g., with or without ascites in alcoholic cirrhosis).

Q5: My patient has transaminitis from metastatic cancer to the liver. What is the correct code?
A: You would code the primary malignant neoplasm with the secondary site in the liver. For example, if the primary is colon cancer, you would code C78.7 (Secondary malignant neoplasm of liver). The transaminitis is a symptom of the metastasis, so R74.0 is not used.

13. Additional Resources

• CDC ICD-10-CM Official Guidelines: https://www.cdc.gov/nchs/icd/icd-10-cm.htm – The definitive source for coding rules and conventions.

• American Health Information Management Association (AHIMA): https://www.ahima.org/ – Provides education, certifications, and resources for medical coders.

• American Association for the Study of Liver Diseases (AASLD): https://www.aasld.org/ – A leading organization for liver health professionals, offering clinical guidance on liver diseases.

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) – Liver Disease: https://www.niddk.nih.gov/health-information/liver-disease – Provides patient and professional education materials.

Date: October 28, 2025
Author: Dr. Jonathan Avery, MD, MPH, CIC
Disclaimer: This article is intended for informational and educational purposes only and does not constitute medical, coding, or legal advice. Medical coding should be performed by a qualified professional based on a complete review of the patient’s medical record and the most current official coding guidelines. Always consult with a healthcare provider for any health concerns.